Works matching IS 14642662 AND DT 2014 AND VI 15 AND IP 4

Results: 10

PEPSE and coke: should we be increasing awareness of HIV post-exposure prophylaxis for consensual risk exposures?
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 255, doi. 10.1111/hiv.12114
By:
- Zimmer, R
Publication type:
Article
Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network ( HYPNet) audit.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 239, doi. 10.1111/hiv.12091
By:
- Fish, R;
- Judd, A;
- Jungmann, E;
- O'Leary, C;
- Foster, C
Publication type:
Article
Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 224, doi. 10.1111/hiv.12107
By:
- Tinago, W;
- O'Halloran, JA;
- O'Halloran, RM;
- Macken, A;
- Lambert, JS;
- Sheehan, GJ;
- Mallon, PWG
Publication type:
Article
Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 213, doi. 10.1111/hiv.12104
By:
- Gutiérrez, F;
- García, L;
- Padilla, S;
- Álvarez, D;
- Moreno, S;
- Navarro, G;
- Gómez‐Sirvent, JL;
- Vidal, F;
- Asensi, V;
- Masiá, M
Publication type:
Article
Expanded HIV testing in high-prevalence areas in England: results of a 2012 audit of sexual health commissioners.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 251, doi. 10.1111/hiv.12099
By:
- Hartney, T;
- Kennedy, I;
- Crook, P;
- Nardone, A
Publication type:
Article
Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up study.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 245, doi. 10.1111/hiv.12094
By:
- Ernst, D;
- Greer, M;
- Akmatova, R;
- Pischke, S;
- Wedemeyer, H;
- Heiken, H;
- Tillmann, HL;
- Schmidt, RE;
- Stoll, M
Publication type:
Article
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 203, doi. 10.1111/hiv.12105
By:
- Sanmartín, R;
- Tor, J;
- Sanvisens, A;
- López, JJ;
- Jou, A;
- Muga, R;
- Ojanguren, I;
- Barluenga, E;
- Videla, S;
- Planas, R;
- Clotet, B;
- Tural, C
Publication type:
Article
Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance.
Published in:
2014
By:
- Llibre, JM;
- Young, B
Publication type:
Editorial
HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 196, doi. 10.1111/hiv.12100
By:
- Mitchell, D;
- Israr, M;
- Alam, S;
- Dinello, D;
- Kishel, J;
- Jia, R;
- Meyers, C
Publication type:
Article
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Published in:
HIV Medicine, 2014, v. 15, n. 4, p. 233, doi. 10.1111/hiv.12083
By:
- Short, C‐ES;
- Douglas, M;
- Smith, JH;
- Taylor, GP
Publication type:
Article